E
agilon health, inc.
AGL
$3.53
-$0.01-0.28%
E
Sell
4/26/2023Downgrade
Agilon Health, Inc. (AGL) was downgraded to E+ from D- on 4/26/2023 due to a decline in the volatility index.
Agilon Health, Inc. (AGL) was downgraded to E+ from D- on 4/26/2023 due to a decline in the volatility index.
D
Sell
4/11/2023Upgraded
Agilon Health, Inc. (AGL) was upgraded to D- from E+ on 4/11/2023 due to a noticeable increase in the total return index and volatility index.
Agilon Health, Inc. (AGL) was upgraded to D- from E+ on 4/11/2023 due to a noticeable increase in the total return index and volatility index.
E
Sell
3/14/2023Downgrade
Agilon Health, Inc. (AGL) was downgraded to E+ from D on 3/14/2023 due to a decline in the growth index, solvency index and valuation index. Operating cash flow declined 1,987.38% from $2.65M to -$49.96M, EBIT declined 139.91% from -$29.01M to -$69.59M, and earnings per share declined from -$0.0746 to -$0.137.
Agilon Health, Inc. (AGL) was downgraded to E+ from D on 3/14/2023 due to a decline in the growth index, solvency index and valuation index. Operating cash flow declined 1,987.38% from $2.65M to -$49.96M, EBIT declined 139.91% from -$29.01M to -$69.59M, and earnings per share declined from -$0.0746 to -$0.137.
D
Sell
2/9/2023Upgraded
Agilon Health, Inc. (AGL) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index and total return index.
Agilon Health, Inc. (AGL) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index and total return index.
E
Sell
2/8/2023Downgrade
Agilon Health, Inc. (AGL) was downgraded to E+ from D on 2/8/2023 due to a decline in the total return index and volatility index.
Agilon Health, Inc. (AGL) was downgraded to E+ from D on 2/8/2023 due to a decline in the total return index and volatility index.
D
Sell
11/7/2022Upgraded
Agilon Health, Inc. (AGL) was upgraded to D from D- on 11/7/2022 due to a noticeable increase in the growth index, volatility index and solvency index. Operating cash flow increased 104.39% from -$60.26M to $2.65M, and total revenue increased 3.69% from $670.13M to $694.86M.
Agilon Health, Inc. (AGL) was upgraded to D from D- on 11/7/2022 due to a noticeable increase in the growth index, volatility index and solvency index. Operating cash flow increased 104.39% from -$60.26M to $2.65M, and total revenue increased 3.69% from $670.13M to $694.86M.
D
Sell
10/19/2022Downgrade
Agilon Health, Inc. (AGL) was downgraded to D- from D on 10/19/2022 due to a decline in the solvency index, volatility index and valuation index. The quick ratio declined from 2.61 to 2.58.
Agilon Health, Inc. (AGL) was downgraded to D- from D on 10/19/2022 due to a decline in the solvency index, volatility index and valuation index. The quick ratio declined from 2.61 to 2.58.
D
Sell
7/21/2022Upgraded
Agilon Health, Inc. (AGL) was upgraded to D from D- on 7/21/2022 due to an increase in the total return index and volatility index.
Agilon Health, Inc. (AGL) was upgraded to D from D- on 7/21/2022 due to an increase in the total return index and volatility index.
D
Sell
5/6/2022Upgraded
Agilon Health, Inc. (AGL) was upgraded to D- from E+ on 5/6/2022 due to an increase in the solvency index, valuation index and growth index. Earnings per share increased from -$0.1431 to $0.0029, EBIT increased 98.39% from -$46.17M to -$743, and operating cash flow increased 52.49% from -$48.9M to -$23.23M.
Agilon Health, Inc. (AGL) was upgraded to D- from E+ on 5/6/2022 due to an increase in the solvency index, valuation index and growth index. Earnings per share increased from -$0.1431 to $0.0029, EBIT increased 98.39% from -$46.17M to -$743, and operating cash flow increased 52.49% from -$48.9M to -$23.23M.
E
Sell
4/20/2022Downgrade
Agilon Health, Inc. (AGL) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index and volatility index.
Agilon Health, Inc. (AGL) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index and volatility index.
D
Sell
11/23/2021Upgraded
agilon health, inc. (AGL) was upgraded to D- from E+ on 11/23/2021.
agilon health, inc. (AGL) was upgraded to D- from E+ on 11/23/2021.
E
Sell
11/8/2021Downgrade
Agilon Health, Inc. (AGL) was downgraded to E+ from D- on 11/8/2021 due to a decline in the total return index and volatility index.
Agilon Health, Inc. (AGL) was downgraded to E+ from D- on 11/8/2021 due to a decline in the total return index and volatility index.
D
Sell
11/3/2021Downgrade
Agilon Health, Inc. (AGL) was downgraded to D- from D on 11/3/2021 due to a significant decline in the volatility index, efficiency index and total return index. Total capital declined 1.74% from $1.21B to $1.18B.
Agilon Health, Inc. (AGL) was downgraded to D- from D on 11/3/2021 due to a significant decline in the volatility index, efficiency index and total return index. Total capital declined 1.74% from $1.21B to $1.18B.
D
Sell
8/6/2021Downgrade
Agilon Health, Inc. (AGL) was downgraded to D from C- on 8/6/2021 due to a major decline in the growth index, valuation index and efficiency index. EBIT declined 2,362.76% from -$12.12M to -$298.36M, net income declined 1,881.99% from -$15.08M to -$298.85M, and earnings per share declined from -$0.0463 to -$0.7918.
Agilon Health, Inc. (AGL) was downgraded to D from C- on 8/6/2021 due to a major decline in the growth index, valuation index and efficiency index. EBIT declined 2,362.76% from -$12.12M to -$298.36M, net income declined 1,881.99% from -$15.08M to -$298.85M, and earnings per share declined from -$0.0463 to -$0.7918.
C
Hold
7/15/2021Upgraded
Agilon Health, Inc. (AGL) was upgraded to C- from D+ on 7/15/2021 due to a large increase in the total return index.
Agilon Health, Inc. (AGL) was upgraded to C- from D+ on 7/15/2021 due to a large increase in the total return index.
D
Sell
7/9/2021None
agilon health, inc. (AGL) was downgraded to D+ from U on 07/09/2021.
agilon health, inc. (AGL) was downgraded to D+ from U on 07/09/2021.
NYSE
03/06/2025 4:00PM Eastern
Quotes delayed
